UP!
| 2016-04-15 | Reiterated Rating | Rodman & Renshaw | Neutral | |
| 2016-04-09 | Downgrade | Rodman & Renshaw | Hold | |
| 2016-04-08 | Downgrade | HC Wainwright | Buy to Neutral | |
| 2016-01-24 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2015-09-01 | Initiated Coverage | HC Wainwright | Buy | $9.00 |
| 2015-08-17 | Reiterated Rating | MLV & Co. | Buy | $20.00 |
| 2015-03-24 | Initiated Coverage | MLV & Co. | Buy | $20.00 |
| 2015-03-23 | Initiated Coverage | MLV & Co. | Buy | $20.00 |
| 2014-12-31 | Reiterated Rating | Aegis | Buy | $15.00 |
| 2014-06-17 | Initiated | Aegis Capital | Buy | $25 |
| 2014-06-17 | Initiated Coverage | Aegis | Buy | $25.00 |
| 2016-04-15 | Reiterated Rating | Rodman & Renshaw | Neutral | |
| 2016-04-09 | Downgrade | Rodman & Renshaw | Hold | |
| 2016-04-08 | Downgrade | HC Wainwright | Buy to Neutral | |
| 2016-01-24 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2015-09-01 | Initiated Coverage | HC Wainwright | Buy | $9.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In NRX 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Care Capital III LLC | 47.89% (4241097) | AGRX / BOTA / NERV / NRX / |
| Seltzer Robert R. | 47.89% (4241097) | NRX / |
| Markham Richard J | 47.89% (4241097) | ACUR / BOTA / NRX / |
| VOGELBAUM MARTIN | 14.98% (1326826) | CARA / NRX / |
| Rho Ventures V, L.P. | 11.89% (1052966) | NRX / |
| Legault Pierre Chief Executive Officer | 7.45% (659430) | FRX / NPSP / NRX / RGDO / |
| Hamill John Chief Financial Officer | 1.54% (136381) | NRX / |
| Patel Jaikrishna Chief Medical Officer | 1.10% (97306) | NRX / |
| Steiner Eugen | 0.86% (76045) | NRX / |
| Peterson Bob VP of Prod. Dev. & Reg Aff\'s. | 0.02% (2000) | NRX / |
UM